These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stem cell transplantation for severe autoimmune diseases: progress and problems. Marmont AM Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258 [TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
4. Pros and cons of stem cell transplantation for autoimmune disease. Thomas ED J Rheumatol Suppl; 1997 May; 48():100-2. PubMed ID: 9150129 [TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541 [No Abstract] [Full Text] [Related]
8. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
10. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675 [TBL] [Abstract][Full Text] [Related]
11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation. Strober S Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Molina A; Popplewell L; Kashyap A; Nademanee A Clin Transpl; 2000; ():317-42. PubMed ID: 11512326 [TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. Szodoray P; Varoczy L; Szegedi G; Zeher M Scand J Rheumatol; 2010; 39(1):1-11. PubMed ID: 20132064 [TBL] [Abstract][Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A; Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114 [TBL] [Abstract][Full Text] [Related]
15. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391 [TBL] [Abstract][Full Text] [Related]
17. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Hinterberger W; Hinterberger-Fischer M; Marmont A Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]